ESR1 and breast cancer: Both MCF-7 and MDA-MB-231 human breast cancer cell lines express low levels of the MT1 receptor [46]; However, overexpression of the MT1 receptor enhanced the growth-inhibitory and gene-modulatory effects of melatonin in ER-positive but not ER-negative human breast cancer cells [49].